In addition to detecting the presence of CD44 on the cell surface and quantifying the levels of the protein, additional studies are looking at transcriptomics to identify and eventually quantify the presence and levels of CD44 isoforms being expressed in bladder cancer cells [50]. The gene discussed is CD44; the disease is urinary bladder carcinoma.